Forte Biosciences Inc (NAS:FBRX)
$ 0.5799 -0.0201 (-3.35%) Market Cap: 21.13 Mil Enterprise Value: -9.31 Mil PE Ratio: 0 PB Ratio: 0.74 GF Score: 42/100

Forte Biosciences Inc Annual Shareholders Meeting Transcript

Jun 01, 2022 / 05:00PM GMT
Release Date Price: $1.27 (-3.79%)
Paul Wagner
Forte Biosciences, Inc. - CEO & Chairman

Good morning, ladies and gentlemen. I am Paul Wagner, and I am the Chief Executive Officer and Chairman of the Board of Directors of Forte Biosciences. It's a pleasure to welcome you to the 2021 virtual annual meeting of stockholders. We will begin today with the formal business of the meeting.

Before proceeding further, I'd like to introduce the company's directors who are present virtually at this meeting. Present are Dr. Lawrence Eichenfield, Steven Kornfeld, Dr. Patricia Walker, and Donald Williams. I would also like to introduce our Chief Financial Officer, Tony Riley, who is present virtually at this meeting.

Finally, I would like to introduce Steve Fanucchi from our auditors Mayer Hoffman McCann, and Ben Capps, our Legal Counsel from Wilson Sonsini Goodrich & Rosati, both of whom are present virtually at this meeting. We've asked Mr. Capps to act as Secretary of the meeting and record the minutes of this meeting.

Also present virtually is Elsie Fletcher of Broadridge Financial Solutions who will serve as the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot